Tropical pulmonary eosinophilia

DIETHYLCARBAMAZINE Diethylcarbamazine is a first-hne agent for control and treatment of lymphatic filariasis and for therapy of tropical pulmonary eosinophilia caused by W. bancrofti and Brugia malayi. Although partially effective against onchocerciasis and loiasis, it can cause serious reactions to affected microfilariae. For this reason, ivermectin has replaced diethylcarbamazine for onchocerciasis. Despite its toxicity diethylcarbamazine remains the best drug available to treat loiasis. 

Vijayan VK. Tropical pulmonary eosinophilia pathogenesis, diagnosis and management. Curr Opin Pulm Med 2007 13 428-433. 

Rom WN, Vijayan VK, Cornelius MJ, et al. Persistent lower respiratory tract inflammation associated with interstitial lung disease in patients with tropical pulmonary eosinophilia following conventional treatment with diethylcarhamazine. Am Rev Respir Dis 1990 142 1088-1092. 

Sandhu M, Mukhopadhyay S, Sharma SK. Tropical pulmonary eosinophilia a comparative evaluation of plain chest radiography and computed tomography. Australas Radiol 1996 40 32-37. 

Cooray JH, Ismail MM. Re-examination of the diagnostic criteria of tropical pulmonary eosinophilia. Respir Med 1999 93 655-659. 

Angioedematous Calabar swellings in Loa loa infections (22). Tropical pulmonary eosinophilia in Wuchereria bancrofti infection (23). 

---